. Nineteen patients died from cardiorespiratory failure. Eight of the survivors are known to have developed respiratory failure, five having enjoyed apparently good health before this was precipitated by intercurrent illness or drugs. A stepwise logistic regression analysis using information from the 124 patients for whom full details were available showed significant associations between the development of cardiorespiratory or respiratory failure and a preoperative contralateral artificial pneumothorax, older age at operation, the presence of cavities before operation, and male sex. In a questionnaire 50 of the survivors (57% of those who replied) reported cough, 45 (51%) breathlessness, 41 (47%) wheeze, and 24 (27%) ankle swelling. Nineteen (22%) smoke and the same number now attend a chest clinic. Many patients treated for tuberculosis by thoracoplasty have respiratory symptoms and some are at risk of respiratory failure. There are grounds for considering that they should be reviewed periodically by a chest physician.
Thoracoplasty was an important form of collapse therapy for pulmonary tuberculosis Most of the patients treated at this time were alive and well a few years after operation,3
" but very little is known of how they have fared in recent years. Perhaps recurrent tuberculosis and the adverse effects on respiratory function of both disease and treatment have already taken a heavy toll among these early survivors, but this information is not available. Undoubtedly some have survived, for they are now seen either with intercurrent illness or with respiratory or cardiac failure, which often seems to be of sudden onset after many years of apparently good health.5 If many patients have indeed survived to the present day adequate provision for the appropriate treatment of such episodes of respiratory failure should now be made. This may include the use of devices to assist ventilation both in hospital and at home. 6 The aims of this study were: (a) to discover how many of the patients treated by thoracoplasty at this hospital in 1951-3 had died by I July 1985; (b) to calculate the proportion in whom respiratory failure is known to have occurred and to identify factors from the time of operation that may have predisposed to its development; (c) to gain some knowledge of the health, lifestyle, and provision for health care of the survivors.
Methods
The number of patients with pulmonary tuberculosis treated by thoracoplasty in Papworth Hospital, 446 Cambridge, from 1 January 1951 to 31 December 1953 was obtained from the theatre operating book. Further information was obtained from the original hospital case notes, where available. Then details of all the patients were sent to the Office of Population, Censuses, and Surveys (OPCS).
MORTALITY
From the replies the survival rate of the patients over 30 years from the date of operation was calculated. A life table for the patients from the year of operation was constructed from the percentage survival to the end of each year of those who could be traced. Allowance was made for patients who emigrated (and who therefore survived to the year of emigration) whose ultimate fate was not known. The hypothetical life table from the year of operation of a "control" group matched for age and sex with all the patients, traced and untraced, was calculated from the mortality statistics serial tables contained in the reviews of the Registrar General on deaths in England and Wales, 1841-1984.7 The survival of the two groups was compared by means of the log rank test.8
CARDIORESPIRATORY FAILURE
For those patients who died in England or Wales before 1 July 1985 the OPCS supplied a copy of the death certificate, from which the date and cause of death were obtained. The causes were divided into three categories: tuberculosis, cardiorespiratory failure, and others. The criterion for inclusion within the category cardiorespiratory failure was either cor pulmonale or respiratory failure stated as the cause of death or death shown to be due to a respiratory condition, with "old pulmonary tuberculosis" named as a contributing factor.
For The questionnaire sent to the general practitioner also asked whether he had been consulted by the patient because of breathlessness within the previous five years, whether the patient was chronically breathless, and whether the patient had ever developed ankle oedema. It asked whether the patient had been prescribed diuretics, digoxin, bronchodilators (inhaled or oral), corticosteroids (inhaled or oral), or domiciliary oxygen. Information about illnesses, including further tuberculosis and its treatment, was sought. Finally details of the patient's attendance at a chest clinic were requested.
A second questionnaire was sent to each surviving patient. It inquired about breathlessness, cough, sputum, wheeze, pain at the site of the thoracoplasty scar, and ankle swelling. The possibility of nocturnal hypoventilation and early morning hypercapnia was explored by questions about interrupted and poor quality sleep at night, snoring, early morning headache, early morning confusion, daytime somnolence, and inability to concentrate. Details of smoking habits were requested. Men were asked whether they had been able to return to the same work after the thoracoplasty. Women were asked whether they could cope with their housework. Both sexes were asked about marriage and children, and whether the scar and deformity produced by the operation had caused them embarrassment. Finally they were asked if they would choose to be seen regularly at a chest clinic.
Comparison was made, using a x2 test, of the symptoms reported by those patients still attending a chest clinic and those who were not, and of the symptoms reported by patients who smoked and those who did not. (2) , left ventricular failure (1), perforated gastric ulcer (1), prescription of a hypnotic drug (1). All five felt that they had been leading normal lives until an abrupt illness of well defined onset. The duration of their symptoms had been from two days to four weeks. Early morning headache was prominent in three. Four of the seven needed mechanical ventilation. One other survivor was found to have hypercapnic respiratory failure (Paco2 6-6 kPa) during an elective admission for investigation of breathlessness. Five of the seven are known to have required readmission, two before I July 1985 and three subsequently. In each case details of the first admission were taken. The mean age of the eight patients with respiratory failure at the time of their first admission was 62-5 years. Thirty five patients (40%) had never smoked. Thirty four (39%) were ex-smokers and 19 (22%) still smoked. Surprisingly, the only significant difference Nineteen patients (22%) still attended a chest clinic. Replies from the others indicated that 63 had been discharged; three had allowed their attendance to lapse while three gave no reason. Cough and breathlessness of some degree were significantly more frequent (p < 0-05) among those who were still attending. Fifty two of the 88 patients (59%) would choose to attend a chest clinic at regular intervals, 30 (34%) would not, and six (7%) were ambivalent about this.
Results

Discussion
These survival figures may cause surprise, given the guarded prognosis that could be given to patients with pulmonary tuberculosis in the days before chemotherapy.'0 The mortality rate for the group we studied is significantly greater than that derived for an age and sex matched population from the Registrar General's mortality figures. Tuberculosis itself does not seem to account for this excess mortality. Indeed, our findings suggest that thoracoplasty met with considerable success in controlling and curing the disease (though we do not know what influence any antituberculous chemotherapy given to our patients in the postoperative years up to 1960 may have had). It has long been recognised that respiratory" and cardiac'2 failure may occur after thoracoplasty, and in our study most of the excess mortality is due to cardiorespiratory failure.
Cardiorespiratory failure is difficult to define satisfactorily for a retrospective survey such as this and we recognise that our definition may not be universally accepted. Furthermore, death certificates may contain inaccuracies."' Nevertheless, we believe that if our criterion was satisfied the patient was very likely to have respiratory failure, or at least severe impairment of respiratory function sufficient to cause respiratory failure during an intercurrent illness, at the time of death.
Our methods may have left undetected some patients who did develop respiratory failure. In particular, any who died from other causes and whose death certificate did not mention their respiratory failure will have been missed. Moreover, surviving patients who have or have had respiratory failure but who have not required admission to hospital within the past five years will not be included. Our overall figure of 27 with respiratory or cardiorespiratory failure out of 158 (17%) is best regarded as a minimum and may well underestimate the true figure.
Overall mortality was, as expected, greater in those who were older at operation. Furthermore, the percentage mortality from cardiorespiratory failure by decade since 1951 has steadily increased as the patients have got older. This suggests that more of the 93 survivors, of whom 71 % were less than 65 years old on I July 1985, are likely to develop cardiorespiratory failure within the next decade.
Seven of the eight surviving patients with respiratory failure have been near to death with severe hypoxaemia and hypercapnia. The striking clinical feature is that five of them had been without symptoms and were leading apparently normal lives until a few days or weeks before their admission. Sawicka et al5 noted this in five of their 10 patients who needed ventilatory assistance for respiratory failure after thoracoplasty. It is worth emphasising that the admission of one of our patients was precipitated by the prescription of a drug causing respiratory depression. Patients with a thoracoplasty who are chronically hypercapnic may be particularly susceptible to the effects of drugs that depress ventilation. Early morning headache, reported by three of our patients, should raise the possibility of nocturnal hypercapnia.
Although some things likely to influence the development of respiratory failure, such as smoking and the inevitable postoperative scoliosis,14 were not investigated, certain factors from the time of operation were linked with the development of cardiorespiratory or respiratory failure and may be useful in identifying patients for whom this is a particular risk. The factor we found to correlate best with subsequent cardiorespiratory or respiratory failure was a previous contralateral artificial pneumothorax. This presumably relates to the high incidence of pleural thickening and fibrosis after artificial pneumothorax, which is often considerable and associated with a severe restrictive ventilatory defect. '15 In patients with a thoracoplasty limitation of expansion of the contralateral lung may be the chief factor determining the development of alveolar hypoventilation and respiratory failure. Older age at operation may reflect more extensive disease2 as well as any effect of aging itself.
The presence of cavities at the time of operation is 450 also likely to reflect more extensive disease and greater residual pulmonary fibrosis. Greater cigarette smoking among the men, before and after the operation, may contribute to their increased likelihood of respiratory failure.
Gaensler et al1 showed that the postoperative decrease in vital capacity after thoracoplasty was directly proportional to the number of ribs resected. Little16 found that the postoperative falls in maximum breathing capacity and FEV1 were also directly related to the number of ribs resected. Gaensler and Strieder"7 showed that a very low postoperative vital capacity was a feature of pneumonectomy with supplementary thoracoplasty. This combination was thought by Huang and Lyons"8 to be particularly likely to cause cardiorespiratory failure. Nevertheless, we did not find any relationship of respiratory failure to the number of ribs resected or to combined pulmonary resection and thoracoplasty.
Some of the survivors seem perfectly well or have mild symptoms in which they may not differ from other people of their age. Most appear to have led normal lives in respect of capability for work, marriage, and child bearing, which were sometimes used to judge the success of a thoracoplasty in restoring patients to normality.2 3 The care of most patients with a thoracoplasty is now in the hands of their general practitioners. It is therefore of concern that replies to the questionnaires show that many have persisting symptoms of respiratory disease that they do not report to their general practitioner. Perhaps they have come to accept their chronic disability and believe that they cannot be helped. Many of them wheeze. This may be due to localised bronchostenosis or generalised bronchial narrowing from tuberculous endobronchitis, but some could have asthma and few are receiving treatment for this. Similarly, some of those who have not disclosed their ankle swelling to their general practitioner may be in heart failure and might benefit from diuretics. Many still smoke; our finding of less breathlessness among those who smoke may indicate that many patients, unless warned of the hazards, will give up smoking only when they become breathless. A few patients have symptoms that suggest chronic nocturnal hypoventilation.
The appropriate management of symptomatic chronic ventilatory failure in patients with a thoracoplasty includes assisted ventilation, best achieved by a device providing negative pressure ventilation.6
Often this need be used only intermittently, usually at night. For those patients who develop ventilatory failure acutely during some intercurrent illness such a device offers an acceptable altermative to intubation and positive pressure ventilation. There are grounds for considering that patients with a thoracoplasty Phillips, Kinnear, Shneerson should be seen at intervals by a physician with special expertise in respiratory medicine, whose remit would be not simply to exclude a recurrence of pulmonary tuberculosis but to seek evidence of respiratory failure and anticipate any need for future ventilatory assistance.
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